Example: Heart Attack

Search clinical trials for: Dose decrease

Total 7785 results

NCT03537326

Completed

Study to Detect Oral Administration of Budesonide in Women. (WADA)

Healthy
NCT01002248

Terminated

Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients

Multiple Myeloma
NCT03323372

Completed

Different Concentrations of Potassium Nitrate in In-office Tooth Bleaching Sensitivity

Tooth Sensitivity
NCT02096419

Completed

Continuous Clopidogrel Dose Adjustment in Acute Coronary Syndrome Patients With High On-treatment Platelet Reactivity

Acute Coronary Syndrome
NCT00590226

Completed

Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes (DEAN)

Type 2 Diabetes
NCT00288041

Completed

Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma

Recurrent Melanoma | Stage IV Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Iris Melanoma | Recurrent Intraocular Melanoma | Extraocular Extension Melanoma
NCT01511887

Completed

Safety and Efficacy of Ibuprofen in Term Newborns With Patent Ductus Arteriosus (PDA)

Patent Ductus Arteriosus
NCT00540410

Completed

Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks

Malaria
NCT00480571

Completed

Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder

Schizophrenia | Schizoaffective Disorder
NCT07169279

Recruiting

Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)

Achondroplasia
NCT06760117

Recruiting

UGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid Tumors

Pediatric Solid Tumor
NCT06720597

Recruiting

EndoPAT Device for Endothelial Dysfunction in ED

Erectile Dysfunction | Endothelial Dysfunction | Hypogonadism, Male
NCT06305910

Recruiting

CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults

Diffuse Midline Glioma, H3 K27M-Mutant | Recurrent High Grade Glioma
NCT06293417

Recruiting

To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM (ENSEMBLE)

Dyslipidemias | T2DM (Type 2 Diabetes Mellitus)
NCT03686124

Recruiting

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors (ACTengine)

Cancer | Solid Tumor, Adult | Refractory Cancer | Recurrent Cancer
NCT03907176

Completed

Study of Post-Herniorrhaphy Non-opioid MMA Regimens

Analgesia
NCT03456817

Terminated

HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis (ATG2017)

Relapse | Graft-versus-host-disease
NCT07053163

Completed

Low Dose of Norepinephrine Within 24-Hour Mortality in Traumatic Patient With Hemorrhagic Shock

Hemorrhagic Shock | Mortality Rate
NCT04080531

Completed

Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders

Plasma Cell Neoplasm
NCT03649633

Terminated

Vitamin C, Steroids, and Thiamine, and Cerebral Autoregulation and Functional Outcome in Septic Shock (CORVICTES-ΥΜ)

Septic Shock
NCT03808961

Terminated

Low Dose Niacin (Vitamin B3) for Parkinson's Disease (NAPS)

Parkinson's Disease
NCT04805541

Completed

Detection and Classification of Diabetic Retinopathy From Posterior Pole Images With A Deep Learning Model

Diabetic Retinopathy | Diabetic Macular Edema | Diabetic Eye Problems
NCT03104725

Terminated

Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease?

Parkinson Disease | Cerebrospinal Fluid
NCT02805660

Terminated

Phase 1/2 Study of Mocetinostat and Durvalumab in Patients With Advanced Solid Tumors and NSCLC

Advanced Cancer
NCT04803162

Active, not recruiting

The Role of HRM and Specific Biomarkers of Inflammation in the Diagnosis of Patients With Dysphagia and Suspected EoE

Eosinophilic Esophagitis
NCT02339324

Completed

Neoadjuvant Combination Biotherapy With Pembrolizumab and High Dose IFN-alfa2b

Melanoma
NCT02505087

Terminated

Pharmacological Treatment of a Rare Genetic Disease: N-acetylcysteine in Myopathy Associated Selenoprotein N-related Myopathy (SEPN1-RM) (SelNac)

Selenoprotein N-related Myopathy
NCT01836289

Withdrawn

High-dose Cyclophosphamide for Severe Refractory Crohn Disease

Crohn's Disease | Crohn Disease
NCT00743366

Completed

Effect of Quetiapine on Marijuana Withdrawal and Relapse

Marijuana Smoking
NCT00761345

Completed

Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer

Metastatic Pancreatic Cancer | Pancreatic Carcinoma Non-resectable
NCT01810952

Completed

The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients (GIH)

Hyperglycemia | Diabetes Mellitus
NCT02851212

Completed

A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin Extended Release Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants

Healthy
NCT01015443

Terminated

Cancer Vaccine Study for Stage III, Unresectable, Non-small Cell Lung Cancer (NSCLC) in the Asian Population (INSPIRE)

Non-Small Cell Lung Cancer
NCT00901823

Withdrawn

Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline

Hypertriglyceridemia
NCT00960115

Completed

Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy

Non-small Cell Lung Cancer
NCT02123654

Completed

UNITY 3: A Japanese Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 in Subjects With Genotype 1 Chronic Hepatitis C

Hepatitis C Virus Infection
NCT00240825

Completed

An Effectiveness and Safety Study of Acetaminophen 1000 mg and Ibuprofen 400 mg in Postoperative Dental Pain.

Pain
NCT02146118

Unknown

A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR Mutant Lung Adenocarcinoma

Carcinoma, Non-Small-Cell Lung
NCT00783731

Completed

Low Dose of Midazolam is Superior to Conventional Dose for Rapid Sequence Intubation in Emergency Department (ED)

Intubation
NCT00179816

Unknown

Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors

Soft Tissue Sarcoma | Hepatoblastoma | Germ Cell Tumor | Hodgkin's Disease | Ewing's Sarcoma
NCT06050993

Completed

Effects of Platelet Mimicking Nanoparticles in Patients With Cirrhosis (HEMCITAP)

Liver Cirrhosis
NCT04427280

Completed

Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19) (CARDS)

Coronavirus Infection | Cancer | Infectious Disease
NCT05077735

Recruiting

Stereotactic Biopsy Split-Course Radiation Therapy in Diffuse Midline Glioma, SPORT-DMG Study

Diffuse Midline Glioma, H3 K27M-Mutant
NCT04430452

Recruiting

Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IIIA Hepatocellular Carcinoma AJCC v8 | Stage IV Hepatocellular Carcinoma AJCC v8 | Stage IVA Hepatocellular Carcinoma AJCC v8 | Stage IVB Hepatocellular Carcinoma AJCC v8 | Stage IIIB Hepatocellular Carcinoma AJCC v8
NCT03972488

Active, not recruiting

Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET (NETTER-2)

Gastro-enteropancreatic Neuroendocrine Tumor
NCT02099825

Terminated

Medication Enhanced Rapid Therapy (MERiT)

Anxiety Disorders
NCT02447432

Completed

A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants

Infections, Streptococcal
NCT01495026

Completed

A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia

Prostatic Hyperplasia
NCT07226635

Completed

Pharmacokinetic Interaction Trial of Clofutriben With Midazolam and Prednisolone (DDI)

Healthy Participants
NCT03013985

Completed

Glargine U300 Hospital Trial

Type 2 Diabetes

Search clinical trials for: Dose decrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations